**Core Concept**
Beta blockers are a class of medications used to manage various cardiovascular conditions, including hypertension, angina, and arrhythmias. However, their metabolism and elimination can be significantly altered in patients with hepatic disease, making some beta blockers safer to use than others in this population.

**Why the Correct Answer is Right**
Among the beta blockers, **Sotalol** is unique because it is not extensively metabolized by the liver. Instead, it is excreted primarily through the kidneys, making it a safer choice in patients with hepatic disease. This is because sotalol does not rely on liver enzymes to break down, reducing the risk of accumulation and toxicity in patients with impaired liver function.

**Why Each Wrong Option is Incorrect**
**Option A:** Metoprolol is primarily metabolized by the liver and can accumulate in patients with hepatic disease, increasing the risk of adverse effects.
**Option B:** Propranolol is also extensively metabolized by the liver and can be affected by changes in liver function, making it less ideal for patients with hepatic disease.
**Option C:** Atenolol is primarily excreted by the kidneys, but it is still metabolized to some extent by the liver, making it less safe than sotalol in patients with severe hepatic disease.

**Clinical Pearl / High-Yield Fact**
When choosing a beta blocker for patients with hepatic disease, it's essential to consider the medication's pharmacokinetics and potential for liver metabolism. Sotalol's unique excretion profile makes it a safer choice in this population.

**Correct Answer:** C. Atenolol